Sorafenib enhances the chemotherapeutic efficacy of S-1 against hepatocellular carcinoma through downregulation of transcription factor E2F-1

✍ Scribed by Zhai, Jing-Ming; Yin, Xiao-Yu; Lai, Ying-Rong; Hou, Xun; Cai, Jian-Peng; Hao, Xiao-Yi; Liang, Li-Jian; Zhang, Long-Juan

• Book ID: 120237346
• Publisher: Springer
• Year: 2013
• Tongue: English
• Weight: 628 KB
• Volume: 71
• Category: Article
• ISSN: 0344-5704
• DOI: 10.1007/s00280-013-2120-2